Hap Trading, LLC Intercept Pharmaceuticals, Inc. Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	BUY	$58.69 - $80.46 $1.38 Million - $1.89 Million	23,495 Added 168.28%	37,457 $2.49 Million
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $1.09 Million - $1.68 Million	13,962 New	13,962 $1.11 Million
Q2 2018 Aug 13, 2018	SELL	$60.0 - $85.67 $1.2 Million - $1.71 Million	-19,980 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$52.72 - $67.25 $1.05 Million - $1.34 Million	19,980 New	19,980 $1.23 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.